1-3 of 3
Richard Tsang, MD, FRCPC
Close
Sort by
Journal Articles

The Impact of Age on the Outcome of Primary Treatment for Classical Hodgkin's Lymphoma: 70 Years of Age Is a Clinical Relevant Cutpoint and the Most Important Predictor of Overall Survival

Lourdes Calvente, MD, Manjula Maganti, MSc, Mary Gospodarowicz, MD FRCPC, David C. Hodgson, MD MPH, FRCPC, Danielle Rodin, MD MPH, FRCPC, Alexander Sun, MD FRCPC, Richard Tsang, MD FRCPC, Robert Kridel, MDMPH,PhD, Vishal Kukreti, MD, Anca Prica, MD, Michael Crump, MD FRCPC, John Kuruvilla, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1559.
https://doi.org/10.1182/blood-2019-130282
Published: 2019
Journal Articles

A Retrospective Study on the Incidence of Rituximab-Related Interstitial Pneumonitis In Patients Undergoing Immunochemotherapy for Non-Hodgkin Lymphoma

Giselle Salmasi, MD, Michael Li, BSc, Vithika Sivabalasundaram, BSc, Richard Tsang, MD, FRCPC, Vishal Kukreti, MD, FRCPC, Michael Crump, MD, FRCPC, John Kuruvilla, MD, FRCPC
Journal: Blood
Blood (2010) 116 (21): 3094.
https://doi.org/10.1182/blood.V116.21.3094.3094
Published: 2010
Journal Articles

Extranodal Follicular Lymphoma - a Retrospective Review and Comparison with Localized Nodal Follicular Lymphoma.

Vishal Kukreti, MD, FRCPC, MSc, Peter Petersen, MD, PHD, Melania Pintilie, Richard Tsang, MD, FRCPC, Michael Crump, MD, FRCPC, Mary Gospodarowicz, MD, FRCPC, FRCR(HON)
Journal: Blood
Blood (2004) 104 (11): 1375.
https://doi.org/10.1182/blood.V104.11.1375.1375
Published: 2004